Characterization and modulation of canine mast cell derived eicosanoids

Veterinary Immunology and Immunopathology

Volumn 135, Issue 1-2, 2010, Pages 118-127

  Lin, Tzu Yin ^a   London, Cheryl A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Eicosanoid; Leukotrienes; Mast cell; NSAID; Prostaglandins

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CARPROFEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINE; DERACOXIB; DEXAMETHASONE; ICOSANOID; INTERLEUKIN 4; LEUKOTRIENE C4; LEUKOTRIENE D4; NONSTEROID ANTIINFLAMMATORY AGENT; NORDIHYDROGUAIARETIC ACID; PIROXICAM; PROSTAGLANDIN D2; PROSTAGLANDIN E2; STEM CELL FACTOR; SUBSTANCE P; TEPOXALIN; UNCLASSIFIED DRUG; ZUBRIN;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW CELL; BONE MARROW CULTURE; CELL STRUCTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; DOG; DRUG EFFECT; DRUG EFFICACY; FATTY ACID ANALYSIS; FATTY ACID SYNTHESIS; IMMUNOMODULATION; IN VITRO STUDY; LIPID COMPOSITION; MAST CELL; MAST CELL DEGRANULATION; MEDIATOR RELEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; STRUCTURE ANALYSIS; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONATE 5-LIPOXYGENASE; CARBAZOLES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; DOGS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENES; MAST CELLS; NORDIHYDROGUAIARETIC ACID; PIROXICAM; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDIN D2; PROSTAGLANDINS; PYRAZOLES; SULFONAMIDES;

CANIS FAMILIARIS;

EID: 77951204809     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2009.11.010     Document Type: Article

References (46)

1. Banks E.M., Coleman J.W. A comparative study of peritoneal mast cells from mutant IL-4 deficient and normal mice: evidence that IL-4 is not essential for mast cell development but enhances secretion via control of IgE binding and passive sensitization. Cytokine 1996, 8:190-196.
2. Beaven M.A. Our perception of the mast cell from Paul Ehrlich to now. Eur. J. Immunol. 2009, 39:11-25.
3. Bochenek G., Nizankowska E., Gielicz A., Swierczynska M., Szczeklik A. Plasma 9alpha, 11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. Thorax 2004, 59:459-464.
4. Boyce J.A. Eicosanoid mediators of mast cells: receptors, regulation of synthesis, and pathobiologic implications. Chem. Immunol. Allergy 2005, 87:59-79.
5. Boyce J.A. Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunol. Rev. 2007, 217:168-185.
6. Brazis P., Torres R., Queralt M., de Mora F., Ferrer L., Puigdemont A. Evaluation of cell-surface IgE receptors on the canine mastocytoma cell line C2 maintained in continuous culture. Am. J. Vet. Res. 2002, 63:763-766.
7. Butterfield J.H., Weiler C.R. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production. Int. Arch. Allergy Immunol. 2008, 147:338-343.
8. Charbeneau R.P., Peters-Golden M. Eicosanoids: mediators and therapeutic targets in fibrotic lung disease. Clin. Sci. (Lond.) 2005, 108:479-491.
9. Claria J., Romano M. Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer. Curr. Pharm. Des. 2005, 11:3431-3447.
10. Colamorea T., Di Paola R., Macchia F., Guerrese M.C., Tursi A., Butterfield J.H., Caiaffa M.F., Haeggstrom J.Z., Macchia L. 5-Lipoxygenase upregulation by dexamethasone in human mast cells. Biochem. Biophys. Res. Commun. 1999, 265:617-624.
11. de Mora F., Puigdemont A., Torres R. The role of mast cells in atopy: what can we learn from canine models? A thorough review of the biology of mast cells in canine and human systems. Br. J. Dermatol. 2006, 155:1109-1123.
12. DeVinney R., Gold W.M. Establishment of two dog mastocytoma cell lines in continuous culture. Am. J. Respir. Cell Mol. Biol. 1990, 3:413-420.
13. Diaz B.L., Fujishima H., Kanaoka Y., Urade Y., Arm J.P. Regulation of prostaglandin endoperoxide synthase-2 and IL-6 expression in mouse bone marrow derived mast cells by exogenous but not endogenous prostanoids. J. Immunol. 2002, 168:1397-1404.
14. Edwards A. The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin. Exp. Allergy 2008, 38:1063-1064. (author reply 1064-1065).
15. Galli S.J., Nakae S., Tsai M. Mast cells in the development of adaptive immune responses. Nat. Immunol. 2005, 6:135-142.
16. Garcia G., Brazis P., Majo N., Ferrer L., de Mora F., Puigdemont A. Comparative morphofunctional study of dispersed mature canine cutaneous mast cells and BR cells, a poorly differentiated mast cell line from a dog subcutaneous mastocytoma. Vet. Immunol. Immunopathol. 1998, 62:323-337.
17. Glitsch M.D., Bakowski D., Parekh A.B. Effects of inhibitors of the lipo-oxygenase family of enzymes on the store-operated calcium current I(CRAC) in rat basophilic leukaemia cells. J. Physiol. 2002, 539:93-106.
18. Goetzl E.J., Phillips M.J., Gold W.M. Stimulus specificity of the generation of leukotrienes by dog mastocytoma cells. J. Exp. Med. 1983, 158:731-737.
19. Grosman N. Comparison of the influence of NSAIDs with different COX-selectivity on histamine release from mast cells isolated from naive and sensitized rats. Int. Immunopharmacol. 2007, 7:532-540.
20. Hua X.Y., Back S.M., Tam E.K. Substance P enhances electrical field stimulation-induced mast cell degranulation in rat trachea. Am. J. Physiol. 1996, 270:L985-991.
21. Hundley T.R., Prasad A.R., Beaven M.A. Elevated levels of cyclooxygenase-2 in antigen-stimulated mast cells is associated with minimal activation of p38 mitogen-activated protein kinase. J. Immunol. 2001, 167:1629-1636.
22. Julemont F., Dogne J.M., Pirotte B., de Leval X. Recent development in the field of dual COX /5-LOX inhibitors. Mini Rev. Med. Chem. 2004, 4:633-638.
23. Kalesnikoff J., Galli S.J. New developments in mast cell biology. Nat. Immunol. 2008, 9:1215-1223.
24. Karimi K., Redegeld F.A., Blom R., Nijkamp F.P. Stem cell factor and interleukin-4 increase responsiveness of mast cells to substance P. Exp. Hematol. 2000, 28:626-634.
25. Kraneveld A.D., van der Kleij H.P., Kool M., van Houwelingen A.H., Weitenberg A.C., Redegeld F.A., Nijkamp F.P. Key role for mast cells in nonatopic asthma. J. Immunol. 2002, 169:2044-2053.
26. 2+ release in mast cells. Am. J. Physiol. 1993, 264:C912-917.
27. Lin T.Y., Bear M., Du Z., Foley K.P., Ying W., Barsoum J., London C. The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors. Exp. Hematol. 2008, 36:1266-1277.
28. Lin T.Y., London C.A. A functional comparison of canine and murine bone marrow derived cultured mast cells. Vet. Immunol. Immunopathol. 2006, 114:320-334.
29. Lin T.Y., Rush L.J., London C.A. Generation and characterization of bone marrow derived cultured canine mast cells. Vet. Immunol. Immunopathol. 2006, 113:37-52.
30. Macrory L., Vaughan-Thomas A., Clegg P.D., Innes J.F. An exploration of the ability of tepoxalin to ameliorate the degradation of articular cartilage in a canine in vitro model. BMC Vet. Res. 2009, 5:25.
31. Mao J.T., Tsu I.H., Dubinett S.M., Adams B., Sarafian T., Baratelli F., Roth M.D., Serio K.J. Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide. Clin. Cancer Res. 2004, 10:6872-6878.
32. Marshall J.S., Jawdat D.M. Mast cells in innate immunity. J. Allergy Clin. Immunol. 2004, 114:21-27.
33. McCann M.E., Andersen D.R., Zhang D., Brideau C., Black W.C., Hanson P.D., Hickey G.J. In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in dogs with experimentally induced synovitis. Am. J. Vet. Res. 2004, 65:503-512.
34. Moon T.C., Lee E., Baek S.H., Murakami M., Kudo I., Kim N.S., Lee J.M., Min H.K., Kambe N., Chang H.W. Degranulation and cytokine expression in human cord blood-derived mast cells cultured in serum-free medium with recombinant human stem cell factor. Mol. Cells 2003, 16:154-160.
35. Nakajima T., Inagaki N., Tanaka H., Tanaka A., Yoshikawa M., Tamari M., Hasegawa K., Matsumoto K., Tachimoto H., Ebisawa M., Tsujimoto G., Matsuda H., Nagai H., Saito H. Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fcepsilon receptor I cross-linking: an interspecies comparison. Blood 2002, 100:3861-3868.
36. Okabe T., Hide M., Hiragun T., Morita E., Koro O., Yamamoto S. Bone marrow derived mast cell acquire responsiveness to substance P with Ca(2+) signals and release of leukotriene B(4) via mitogen-activated protein kinase. J. Neuroimmunol. 2006, 181:1-12.
37. Olivry T., Marsella R., Hillier A. The ACVD task force on canine atopic dermatitis (XXIII): are essential fatty acids effective?. Vet. Immunol. Immunopathol. 2001, 81:347-362.
38. Phillips M.J., Gold W.M., Goetzl E.J. IgE-dependent and ionophore-induced generation of leukotrienes by dog mastocytoma cells. J. Immunol. 1983, 131:906-910.
39. Puxeddu I., Piliponsky A.M., Bachelet I., Levi-Schaffer F. Mast cells in allergy and beyond. Int. J. Biochem. Cell Biol. 2003, 35:1601-1607.
40. Robin J.L., Seldin D.C., Austen K.F., Lewis R.A. Regulation of mediator release from mouse bone marrow derived mast cells by glucocorticoids. J. Immunol. 1985, 135:2719-2726.
41. Schleimer R.P., Schulman E.S., MacGlashan D.W., Peters S.P., Hayes E.C., Adams G.K., Lichtenstein L.M., Adkinson N.F. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J. Clin. Invest. 1983, 71:1830-1835.
42. Sewell W.A., Scurr L.L., Orphanides H., Kinder S., Ludowyke R.I. Induction of interleukin-4 and interleukin-5 expression in mast cells is inhibited by glucocorticoids. Clin. Diagn. Lab. Immunol. 1998, 5:18-23.
43. Wilson J.E., Chandrasekharan N.V., Westover K.D., Eager K.B., Simmons D.L. Determination of expression of cyclooxygenase-1 and -2 isozymes in canine tissues and their differential sensitivity to nonsteroidal anti-inflammatory drugs. Am. J. Vet. Res. 2004, 65:810-818.
44. Wu X., Dev A., Leong A.B. Zileuton, a 5-lipoxygenase inhibitor, increases production of thromboxane A2 and platelet aggregation in patients with asthma. Am. J. Hematol. 2003, 74:23-25.
45. Yakabi K., Arimura T., Koyanagi M., Uehigashi Y., Ro S., Minagawa Y., Nakamura T. Effects of interleukin-8 and Helicobacter pylori on histamine release from isolated canine gastric mucosal mast cells. J. Gastroenterol. 2002, 37:10-16.
46. Zhou J., Liu D.F., Liu C., Kang Z.M., Shen X.H., Chen Y.Z., Xu T., Jiang C.L. Glucocorticoids inhibit degranulation of mast cells in allergic asthma via nongenomic mechanism. Allergy 2008, 63:1177-1185.